Abbott Laboratories Inc. seemed to score a recent victory in an ongoing patent dispute over transcatheter mitral valve repair technology, as a Delaware federal judge largely sided with the company in a 22 October court order.
The dispute concerns five patents held by Abbott, which the firm claims are being violated by Edwards Lifesciences Corp.’s Pascal transcatheter mitral valve repair device. Abbott’s MitraClip is currently...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?